SEARCH

S & T » Health

Updated: December 6, 2009 19:27 IST

Stem cells may cure spina bifida: AIIMS doctors

PTI
print   ·   T  T  
Institute of Kidney Diseases and Research Centre Director Dr. H.L. Trivedi, explains how human mesenchymal stem cells from fat tissue can repair a damaged heart during a press conference in Ahmedabad. File photo: AP.
Institute of Kidney Diseases and Research Centre Director Dr. H.L. Trivedi, explains how human mesenchymal stem cells from fat tissue can repair a damaged heart during a press conference in Ahmedabad. File photo: AP.

Stem cells have the potential to cure kidney diseases and “incurable” spina bifida (a neurological deficit) said doctors at AIIMS after conducting a five-year study on the potential of stem cells in these areas.

“Stem cells have the potential to repair and regenerate the kidney tissue. It has also shown positive results in cases of spina bifida, where people remain handicapped even after undergoing a surgery for it,” Professor D K Gupta, paediatric surgeon, AIIMS said here today.

“Use of stem cells in regenerating kidney tissue was a challenging task as the vital organ is made up of many different types of cells. With research work carried out in India and abroad, we can conclude that it has a potential in treating kidney diseases,” Dr Shilpa Sharma paediatric surgeon, Ram Manohar Lohia hospital, said.

The team at Stem Cell Facility, AIIMS has been carrying out research work on the potential of stem cells in different areas since 2005. It has an in-house umbilical cord blood bank at AIIMS that harnesses the potential of umbilical cord stem cells.

“We can conclude after five years of our research work that autologus (one’s own body) stem cells have not shown any cancerous transformation on anyone who has undergone a stem cell treatment. Mothers who have children with congenital anomalies should store their cod blood for future use,” Prof Gupta said.

More In: Health | Sci-Tech


O
P
E
N

close

Recent Article in Health

Research assistant Georgina Bowyer works on a vaccine for Ebola at The Jenner Institute in Oxford, southern England on January 16, 2015.

Ebola vaccine safe, generates immune response, shows trial

The first trial results of Ebola vaccine at Oxford University suggest the vaccine has an acceptable safety profile and is able to generat... »